South Dakota Investment Council United Therapeutics Corp Transaction History

South Dakota Investment Council

$4.81 Billion
Q1 2024

A detailed history of South Dakota Investment Council transactions in United Therapeutics Corp stock. As of the latest transaction made, South Dakota Investment Council holds 9,838 shares of UTHR stock, worth $3.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,838

Previous 10,638 7.52%

Holding current value

$3.12 Million

Previous $2.34 Million 3.38%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$210.76 - $249.51 $168,608 - $199,608	-800 Reduced 7.52%	9,838 $2.26 Million
Q3 2023 Nov 07, 2023	SELL	$211.82 - $248.24 $105,910 - $124,120	-500 Reduced 4.49%	10,638 $2.4 Million
Q2 2023 Aug 10, 2023	SELL	$205.19 - $232.99 $354,773 - $402,839	-1,729 Reduced 13.44%	11,138 $2.46 Million
Q1 2023 May 10, 2023	SELL	$212.99 - $276.17 $3.51 Million - $4.56 Million	-16,500 Reduced 56.19%	12,867 $2.88 Million
Q2 2022 Aug 11, 2022	SELL	$174.81 - $241.14 $2.84 Million - $3.91 Million	-16,229 Reduced 35.59%	29,367 $6.92 Million

Q1 2022 May 10, 2022	SELL	$166.16 - $213.96 $4.13 Million - $5.32 Million	-24,878 Reduced 35.3%	45,596 $8.18 Million
Q3 2021 Nov 09, 2021	SELL	$179.86 - $214.88 $449,650 - $537,200	-2,500 Reduced 3.43%	70,474 $13 Million
Q2 2021 Aug 11, 2021	BUY	$170.47 - $211.93 $272,752 - $339,088	1,600 Added 2.24%	72,974 $13.1 Million
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $1.3 Million - $1.48 Million	-8,448 Reduced 10.58%	71,374 $11.9 Million
Q3 2020 Nov 06, 2020	SELL	$99.9 - $121.13 $211,788 - $256,795	-2,120 Reduced 2.59%	79,822 $8.06 Million
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $457,208 - $620,292	-4,930 Reduced 5.68%	81,942 $9.92 Million
Q1 2020 May 11, 2020	BUY	$79.39 - $115.35 $523,338 - $760,387	6,592 Added 8.21%	86,872 $8.24 Million
Q4 2019 Feb 11, 2020	SELL	$78.31 - $95.34 $678,164 - $825,644	-8,660 Reduced 9.74%	80,280 $7.07 Million
Q3 2019 Nov 13, 2019	BUY	$74.85 - $85.99 $3.34 Million - $3.84 Million	44,640 Added 100.77%	88,940 $7.09 Million
Q2 2019 Aug 13, 2019	BUY	$76.06 - $120.81 $235,786 - $374,511	3,100 Added 7.52%	44,300 $3.46 Million
Q1 2019 May 03, 2019	SELL	$107.15 - $126.84 $21,430 - $25,368	-200 Reduced 0.48%	41,200 $4.84 Million
Q4 2018 Feb 06, 2019	BUY	$101.4 - $128.73 $50,700 - $64,364	500 Added 1.22%	41,400 $4.51 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $1.05 Million - $1.19 Million	-9,200 Reduced 18.36%	40,900 $5.23 Million
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $806,344 - $1.03 Million	-6,800 Reduced 11.95%	50,100 $7.41 Million
Q3 2017 Nov 09, 2017	BUY	$114.6 - $136.81 $6.52 Million - $7.78 Million	56,900	56,900 $6.67 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council United Therapeutics Corp Transaction History